Literature DB >> 35987923

The identification of association between ultrasonographic enthesitis and the ASAS Health Index in patients with axial spondyloarthritis.

Abdulvahap Kahveci1, Yuzlem Gyuner Sıdzhımlı2, Seçilay Güneş2, Alper Gümüştepe3, Caner Baysan4, Şebnem Ataman3.   

Abstract

This study aimed to evaluate association between the entheseal abnormalities in ultrasound and the Assessment of Spondyloarthritis International Society Health Index (ASAS HI) in patients with axial spondyloarthritis (axSpA). Seventy-four patients with axSpA were enrolled in this study. Ultrasonographic evaluation of entheses was performed by a blinded rheumatologist with the Madrid Sonographic Enthesitis Index (MASEI). The MASEI total score and the MASEI sub-scores (e.g., structural damage and activity scores) were calculated. The ASAS HI and the other SpA tools (e.g., Bath Ankylosing Spondylitis Disease Index, the Ankylosing Spondylitis Disease Activity Score) were used to evaluate patients' health and disease activity. Correlation and multivariate linear regression analyses were performed to assess the relationship between the MASEI and the ASAS HI. The mean score of the ASAS HI was 7.7 ± 4.6. The MASEI total score was calculated as 8.4 ± 6.8, while the mean MASEI-activity was 4.7 ± 3.6 and the mean MASEI-structural damage was 3.8 ± 4.5. There was no correlation between ASAS HI and MASEI total scores (r = 0.11, p = 0.34). However, the ASAS HI had a positive correlation with the MASEI-activity (r = 0.49, p < 0.001) and had a low negative correlation with the MASEI-structural damage (r = - 0.29, p < 0.05). In the linear regression model, the MASEI-activity and MASEI-structural damage were significantly related to the ASAS HI (β = 0.72 and - 0.58, respectively; R2 = 0.53 p < 0.001). This study reported that the ASAS HI score was more negatively affected by active entheseal lesions rather than structural lesions. We suggest adding the entheses evaluation with ultrasonography to other tools for monitoring the health status of patients with axSpA.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  ASAS Health Index; Axial spondyloarthritis; Enthesitis; MASEI; Musculoskeletal ultrasonography

Year:  2022        PMID: 35987923     DOI: 10.1007/s00296-022-05188-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  30 in total

Review 1.  Ultrasound imaging in spondyloarthropathies.

Authors:  Maria Antonietta D'Agostino
Journal:  Best Pract Res Clin Rheumatol       Date:  2010-10       Impact factor: 4.098

Review 2.  Enthesitis: from pathophysiology to treatment.

Authors:  Georg Schett; Rik J Lories; Maria-Antonietta D'Agostino; Dirk Elewaut; Bruce Kirkham; Enrique R Soriano; Dennis McGonagle
Journal:  Nat Rev Rheumatol       Date:  2017-11-21       Impact factor: 20.543

3.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

4.  Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS.

Authors:  U Kiltz; D van der Heijde; A Boonen; A Cieza; G Stucki; M A Khan; W P Maksymowych; H Marzo-Ortega; J Reveille; S Stebbings; C Bostan; J Braun
Journal:  Ann Rheum Dis       Date:  2014-01-07       Impact factor: 19.103

Review 5.  Hidden in plain sight: Is there a crucial role for enthesitis assessment in the treatment and monitoring of axial spondyloarthritis?

Authors:  Dennis McGonagle; Sibel Z Aydin; Helena Marzo-Ortega; Lihi Eder; Coziana Ciurtin
Journal:  Semin Arthritis Rheum       Date:  2021-07-09       Impact factor: 5.532

6.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

7.  Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index.

Authors:  W P Maksymowych; C Mallon; S Morrow; K Shojania; W P Olszynski; R L Wong; J Sampalis; B Conner-Spady
Journal:  Ann Rheum Dis       Date:  2008-06-04       Impact factor: 19.103

8.  Assessment of enthesitis in ankylosing spondylitis.

Authors:  L Heuft-Dorenbosch; A Spoorenberg; A van Tubergen; R Landewé; H van ver Tempel; H Mielants; M Dougados; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2003-02       Impact factor: 19.103

9.  Validity of enthesis ultrasound assessment in spondyloarthropathy.

Authors:  E de Miguel; T Cobo; S Muñoz-Fernández; E Naredo; J Usón; J C Acebes; J L Andréu; E Martín-Mola
Journal:  Ann Rheum Dis       Date:  2008-04-07       Impact factor: 19.103

10.  Clinical performance of ASAS Health Index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: real-world evidence from Multicenter Nationwide Registry.

Authors:  Ozgur Akgul; Hatice Bodur; Sebnem Ataman; Fatma Gul Yurdakul; Erhan Capkin; Gulcan Gurer; Ilhan Sezer; Mehmet Tuncay Duruoz; Meltem Alkan Melikoglu; Hasan Fatih Cay; Aylin Rezvani; Ilker Yagci; Feride Gogus; Ayhan Kamanli; Remzi Cevik
Journal:  Rheumatol Int       Date:  2020-08-19       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.